Skip to main content
THERACRYF PLC logo

THERACRYF PLC — Investor Relations & Filings

Ticker · TCF ISIN · GB00BSVYN304 LEI · 213800NO3E6TSTQO8K20 IL Professional, scientific and technical activities
Open in API
Filings indexed 362 across all filing types
Latest filing 2019-03-05 Regulatory Filings
Country GB United Kingdom
Listing IL TCF

About THERACRYF PLC

https://theracryf.com/

TheraCryf PLC is a clinical-stage therapeutics company focused on developing a new generation of innovative medicines for behavioural brain disorders and oncology. The company's research and development efforts are centered on sulforaphane-based compounds. Its primary therapeutic focus is on conditions such as opioid and alcohol abuse, binge eating disorder, anxiety, and fatigue. TheraCryf's business strategy is to generate compelling clinical data for its drug candidates with the goal of partnering its programs with larger pharmaceutical companies for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
SFX-01 data published in peer reviewed journal
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from the London Stock Exchange regarding the publication of scientific research data in a peer-reviewed journal. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a corporate governance or management change notice. As it is a general regulatory announcement regarding company news, it falls under the RNS fallback category.
2019-03-05 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Evgen Pharma PLC. It details the acquisition of voting rights by Partners Investment Company LLP, crossing a specific threshold. This is a classic regulatory disclosure regarding significant share ownership, which falls under the 'Major Shareholding Notification' category.
2019-02-06 English
Clinical trial update confirms read-outs on track
Regulatory Filings Classification · 98% confidence The document is a regulatory news service (RNS) announcement from Evgen Pharma PLC regarding clinical trial updates for their SAS and STEM trials. It provides operational progress and expected timelines for data read-outs. Since it is a general corporate announcement regarding business operations and clinical milestones that does not fit into specific categories like financial reports, dividends, or director dealings, it is classified as a Regulatory Filing (RNS).
2019-02-05 English
Grant of Options
Director's Dealing Classification · 100% confidence The document is an official notification of a 'Grant of Options' to Persons Discharging Managerial Responsibility (PDMRs) at Evgen Pharma PLC. It includes the specific regulatory disclosure tables required for director/executive share transactions (PDMR notifications). This falls under the 'Director's Dealing' category, as it reports the acquisition of share options by company executives.
2019-01-30 English
SFX-01 featured in Nature Reviews Drug Discovery
Regulatory Filings Classification · 98% confidence The document is a press release distributed via the London Stock Exchange's RNS (Regulatory News Service). It announces that the company's lead product, SFX-01, was featured in a scientific journal article. As this is a general corporate announcement that does not fit into specific categories like financial reports, dividends, or board changes, it falls under the 'Regulatory Filings' (RNS) category.
2019-01-23 English
Change of Adviser
Regulatory Filings Classification · 98% confidence The document is an announcement regarding a change in the company's Nominated Adviser and Joint Broker. This falls under corporate management and board-related changes. While it is distributed via RNS, it is specifically a management/advisory change announcement, which fits the 'MANG' category for Board/Management Information.
2019-01-22 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.